Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Abuse liability (1)
- Administration, Oral (1)
- Attention (1)
- Attentional bias (1)
- Behavior Therapy (1)
-
- CBD (1)
- Cannabidiol (1)
- Cocaine-Related Disorders (1)
- Cocaine-use disorders (1)
- Cues (1)
- Double-Blind Method (1)
- Drug Interactions (1)
- Drug Users (1)
- Executive Function (1)
- Heart Rate (1)
- Human (1)
- Inhibition (Psychology) (1)
- Inhibitory control training (1)
- Marijuana Abuse (1)
- Marijuana Smoking (1)
- Neuropsychological Tests (1)
- Pilot Projects (1)
- Psychomotor Performance (1)
- Response inhibition (1)
- Smoked marijuana (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
A Pilot Investigation Of Acute Inhibitory Control Training In Cocaine Users, Joseph L. Alcorn, Erika Pike, William W. Stoops, Joshua A. Lile, Craig R. Rush
A Pilot Investigation Of Acute Inhibitory Control Training In Cocaine Users, Joseph L. Alcorn, Erika Pike, William W. Stoops, Joshua A. Lile, Craig R. Rush
Behavioral Science Faculty Publications
Background—Disrupted response inhibition and presence of drug-cue attentional bias in cocaine-using individuals have predicted poor treatment outcomes. Inhibitory control training could help improve treatment outcomes by strengthening cognitive control. This pilot study assessed the effects of acute inhibitory control training to drug- and non-drug-related cues on response inhibition performance and cocaine-cue attentional bias in cocaine-using individuals.
Methods—Participants who met criteria for a cocaine-use disorder underwent five sessions of inhibitory control training to either non-drug-related cues (i.e., rectangles) or cocaine cues (n=10/condition) in a single day. Response inhibition and attentional bias were assessed prior to and following training using …
Oral Cannabidiol Does Not Produce A Signal For Abuse Liability In Frequent Marijuana Smokers, Shanna Babalonis, Margaret Haney, Robert J. Malcolm, Michelle R. Lofwall, Victoria R. Votaw, Steven Sparenborg, Sharon L. Walsh
Oral Cannabidiol Does Not Produce A Signal For Abuse Liability In Frequent Marijuana Smokers, Shanna Babalonis, Margaret Haney, Robert J. Malcolm, Michelle R. Lofwall, Victoria R. Votaw, Steven Sparenborg, Sharon L. Walsh
Behavioral Science Faculty Publications
Background—Cannabidiol (CBD) is a naturally occurring constituent of the marijuana plant. In the past few years, there has been great interest in the therapeutic effects of isolated CBD and it is currently being explored for numerous disease conditions (e.g., pain, epilepsy, cancer, various drug dependencies). However, CBD remains a Schedule I drug on the U.S. Controlled Substances Act (CSA). Despite its status, there are no well-controlled data available regarding its abuse liability.
Methods—Healthy, frequent marijuana users (n=31) were enrolled in this within subject, randomized, placebo-controlled, double-blind, multisite study that administered oral cannabidiol (0, 200, 400, 800 …